UltraSight (Tel Aviv, Israel) announced a collaboration with Mayo Clinic to enhance cardiac care through using AI in point-of-care ultrasound. The partnership involves UltraSight and Mayo Clinic jointly developing algorithms for analysing and interpreting cardiac ultrasound images. The goal is an end-to-end solution and decision support to help healthcare providers make more informed diagnoses and treatment decisions.
Related: Edwards Lifesciences to Sell Critical Care to BD
Rochester, Minnesota–based Mayo Clinic is now an investor in UltraSight, according to the company. Financial terms of the investment were undisclosed. On top of the funding, UltraSight gains access to researchers, clinicians and data at one of the top health providers in the world.
“Mayo Clinic and UltraSight will work together to enable a wider spectrum of caregivers to obtain cardiac ultrasound data and understand the results, serving many more patients globally,” Dr. John Halamka, president of Mayo Clinic Platform, said in a news release.
UltraSight CEO Davidi Vortman said that obtaining diagnostic-quality cardiac images at the patient’s point of care is only the first step. “We firmly believe that point-of-care ultrasound, when enhanced by the capabilities of AI, holds potential to optimize patient care. Through this collaboration, we plan to enhance our solution to detect and manage cardiac conditions in a more scalable and cost-effective way, ultimately helping more patients receive timely treatment.”
